Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
GEN Roundup: Multiplex Immunoassays Bring the Array, Not the Disarray
Get Multiplex Immunoassay Advice from GEN's Expert Panel
Alan J. Russell Ph.D.
Alan Russell (Ph.D. in Biological Chemistry, 1987, Imperial College of Science and Technology, University of London) is the Highmark Distinguished Professor in the Institute for Complex and Engineered Systems at Carnegie Mellon University. He is also the executive director of the Pittsburgh Tissue Engineering Initiative and the director of the National Tissue Engineering Center.
Dr. Russell was the founding director of the McGowan Institute for Regenerative Medicine, jointly established by the University of Pittsburgh School of Medicine and UPMC Health System as a center of expertise and education in therapies that reestablish tissue and organ function. The McGowan Institute is a center for research and clinical work in tissue engineering, adult-derived stem cell research and cellular therapies, biosurgery, and artificial and biohybrid organ devices. He was also founding president of the 3,000-member Tissue Engineering and Regenerative Medicine International Society.
He has given more than 250 national and international invited lectures. He holds 14 patents and has 23 patents pending.
More GEN Content From This Contributor
- Biopharmaceutical: Alan J. Russell, Ph.D.
- Biopharmaceutical: <i>Disruptive Science and Technology</i>: A New Journal
- Columns: Disrupting Alzheimer’s Disease Research